Van Chanh Ngo

Brivanib Alaninate, a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Tyrosine Kinases, Induces Growth Inhibition in Mouse Models of Human Hepatocellular Carcinoma

Hung Huynh, Van Chanh Ngo, Joseph Fargnoli et al. · Clinical Cancer Research · 2008 · 221 citations · Full text

Medicine, Oncology, Pharmacology +17

RAD001 (everolimus) inhibits tumour growth in xenograft models of human hepatocellular carcinoma

Hung Huynh, Pierce K. H. Chow, Khee Chee Soo et al. · Journal of Cellular and Molecular Medicine · 2008 · 135 citations · Full text

Medicine, Oncology, Pharmacology +17

Sorafenib and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma

Hung Huynh, Van Chanh Ngo, Heng Nung Koong et al. · Journal of Cellular and Molecular Medicine · 2009 · 130 citations · Full text

Medicine, Oncology, Pharmacology +17

AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)

Hung Huynh, Van Chanh Ngo, Heng Nung Koong et al. · Journal of Hepatology · 2009 · 99 citations

Medicine, Oncology, Pharmacology +15

Sorafenib induces growth suppression in mouse models of gastrointestinal stromal tumor

Hung Huynh, Jonathan Lee, Pierce K. H. Chow et al. · Molecular Cancer Therapeutics · 2009 · 56 citations

Medicine, Oncology, Pharmacology +14